1-5 of 5
Jad Bsat, BA
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Rituximab/Bendamustine and Rituximab/Cytarabine (RB/RC) Induction Chemotherapy for Transplant-Eligible Patients with Mantle Cell Lymphoma: A Pooled Analysis of Two Phase 2 Clinical Trials and Off-Trial Experience

Reid W Merryman, MD, Brad S Kahl, MD, Robert A. Redd, MS, Jad Bsat, BA, Matthew Lewis Chase, Ann S. LaCasce, MD MSc, Arnold S. Freedman, MD, Caron A. Jacobson, MD, David C. Fisher, MD, Samuel Y. Ng, MDPhD, Jennifer L Crombie, MD, Austin I Kim, MD, Oreofe O. Odejide, MD, Matthew S. Davids, MD, Jennifer R. Brown, MD PhD, Heather A. Jacene, Mehta-Shah Neha, Natasha Edwin, MD, Amanda F Cashen, MD, Nancy L. Bartlett, MD, Armin Ghobadi, MD, Philippe Armand, MD PhD, Robin M. Joyce, MD, Eric D Jacobsen, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 145.
https://doi.org/10.1182/blood-2018-99-110520
Published: 2018
Journal Articles

PD-1 Blockade for Diffuse Large B-Cell Lymphoma after Autologous Stem Cell Transplantation

Yi-Bin Chen, MD, Philippe Armand, MD PhD, Robert A. Redd, MS, Jad Bsat, BA, Reid W Merryman, MD, Kimberly Coleman, RN, Alex F. Herrera, MD, Parastoo B. Dahi, MD, Yago Nieto, MD PhD, Ann S. LaCasce, MD MSc, David C. Fisher, MD, Samuel Y. Ng, MDPhD, Oreofe O. Odejide, MD, Arnold S. Freedman, MD, Austin I Kim, MD, Jennifer L Crombie, MD, Caron A. Jacobson, MD, Eric D Jacobsen, MD, Jeffrey L Wong, MD PhD, Sanjay S Patel, MD MSc, MPH, Jerome Ritz, MD PhD, Scott J Rodig, MDPhD, Margaret A. Shipp, MD, Robin M. Joyce, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 706.
https://doi.org/10.1182/blood-2018-99-114914
Published: 2018
Journal Articles

PD-1 Blockade with Pembrolizumab for Classical Hodgkin Lymphoma after Autologous Stem Cell Transplantation

Philippe Armand, MD PhD, Yi-Bin Chen, MD, Robert A. Redd, MS, Robin M. Joyce, MD, Jad Bsat, BA, Reid W Merryman, MD, Kimberly Coleman, RN, Parastoo B. Dahi, MD, Yago Nieto, MD PhD, Ann S. LaCasce, MD MSc, David C. Fisher, MD, Samuel Y. Ng, MDPhD, Oreofe O. Odejide, MD, Arnold S. Freedman, MD, Austin I Kim, MD, Jennifer L Crombie, MD, Caron A. Jacobson, MD, Eric D Jacobsen, MD, Jeffrey L Wong, MD PhD, Mikel Lipschitz, M.S., Sanjay S Patel, MD MSc, MPH, Jerome Ritz, MD PhD, Scott J Rodig, MDPhD, Margaret A. Shipp, MD, Alex F Herrera, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 1650.
https://doi.org/10.1182/blood-2018-99-113685
Published: 2018
Journal Articles

A Multicenter, Phase II Study of Ibrutinib Plus FCR (iFCR) As Frontline Therapy for Younger CLL Patients

Matthew S. Davids, MD, Haesook T Kim, PhD, Danielle M. Brander, MD, Jad Bsat, BA, Alexandra Savell, BS, Karen Francoeur, RN, Caron Jacobson, MD, Samuel Y. Ng, MDPhD, Ann S LaCasce, MD MSc, Ephraim P. Hochberg, MD, Ronald W. Takvorian, MD, Jeremy S. Abramson, MD MMSc, David C. Fisher, MD PhD, Jennifer R. Brown, MD PhD
Journal: Blood
Blood (2017) 130 (Supplement 1): 496.
https://doi.org/10.1182/blood.V130.Suppl_1.496.496
Published: 2017
Journal Articles

Initial Results of a Multicenter, Phase II Study of Ibrutinib Plus FCR (iFCR) As Frontline Therapy for Younger CLL Patients

Matthew S. Davids, Haesook T. Kim, PhD, Danielle M. Brander, MD, Jad Bsat, BA, Alexandra Savell, BS, Karen Francoeur, RN, Jeffrey Hellman, PA-C, Caron A. Jacobson, MD, Ephraim Hochberg, MD, Ronald Takvorian, MD, Jeremy S. Abramson, MD, David C. Fisher, MD, Jennifer R. Brown, MD PhD
Journal: Blood
Blood (2016) 128 (22): 3243.
https://doi.org/10.1182/blood.V128.22.3243.3243
Published: 2016